Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5551–5600 of 34704
the Board appointed Kevin Warren to the Board and to the Compensation and Talent Committee of the Board, effective January 15, 2025, subject to customary regulatory approval.
Leonard Schlesinger as a director of the Company
Lars Albright as a director of the Company
Diane Hessan as a director of the Company
the Board increased the number of members of the Board from 7 to 8 and appointed Franziska Michor, Ph.D., (“Dr. Michor”) as a Class II Director of the Board
On November 19 , 2024 , the Board of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed Steven L. Hoerter as a director of the Company.
Our Company’s current sole Director and officer Alfredo Papadakis has resigned, and Ken Williams has been appointed as sole director and President, Secretary and CFO.
Karen Walker notified the Board of her resignation from the Board effective December 31, 2024.
Brian J. Lipke informed the Board of Directors (the “Board”) of Moog Inc. (the “Company”) that he intends to retire from the Board immediately prior to the Company’s 2025 annual meeting of shareholders
On November 13, 2024, Stacy Loretz-Congdon communicated to the Board of Directors (the “Board”) of Farmer Bros. Co., a Delaware corporation (the “Company”), her decision not to stand for reelection as a member of the Board at the Company’s 2025 Annual Meeting of Stockholders.
On November 15, 2024, Mr. Vig informed the Company that his resignation as Director of the Company will be effective as of the close of business on November 15, 2024.
On November 15, 2024, the Board of Directors of the Company (the “Board”) appointed Peter Schwab to the Board, effective as of the close of business on November 15, 2024, to serve until the end of his term at the close of business on May 18, 2025.
On November 15, 2024, the Board of Trustees of the Company (the “Board”) appointed Peter Schwab to the Board as a Class III Trustee, effective as of the close of business on November 15, 2024
On November 15, 2024, Mr. Vig informed the Company that his resignation as a Trustee of the Company will be effective as of the close of business on November 15, 2024.
appointed Shamla Naidoo to serve as a member of the Board effective January 1, 2025.
On November 19, 2024, the Board of Directors (the “Board”) of BlackRock, Inc. (the “Company”) elected Adebayo Ogunlesi to serve as a director.
On November 19, 2024, the Board of Directors (the “Board”) of Hubbell Incorporated (the “Company”) elected Garrick J. Rochow as an independent director of the Company, effective as of that date (the “Effective Date”).
On November 19, 2024, the Board of Directors (the “Board”) of LegalZoom.com, Inc. (the “Company”) appointed Nathan Gooden to serve as an independent Class I director of the Board, effective immediately.
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
the Board of Directors appointed Timothy Brocopp (“Mr. Brocopp”) to serve as an independent director of the Company
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Mr. Malafronte will continue to serve on the Board as Lead Independent Director, Chair of the Compensation Committee, and a member of the Academic Quality Committee.
On November 14, 2024, Andrew Call submitted his resignation as a member of the Board of Directors (the “Board”), as well as from his position as Chair of the Audit Committee of the Board, effective immediately.
On November 14, 2024, the Board of Directors of The Boeing Company (the “Company”) elected Mortimer J. (Tim) Buckley, former Chairman and Chief Executive Officer of The Vanguard Group, as a director effective January 1, 2025.
On November 15, 2024, the Board appointed and elected Heather Turner as a member of the Board, effective as of November 18, 2024.
On November 14, 2024, Ann Taylor notified Terns Pharmaceuticals, Inc. (the “Company”) of her resignation from the Company’s Board of Directors (the “Board”), effective as of November 18, 2024.
Mr. Yal will also join the Board of Directors (the "Board") at that time, with the size of the Board increasing from seven members to eight.
On November 18, 2024, the Board of Directors (the “Board”) of 8x8, Inc. (the “Company”) appointed John Pagliuca to the Board.
created by the resignation of Francisco J. Coll.
On November 12, 2024, the Company’s Board appointed Skyler M. Howton to fill the vacancy in the Board created by the resignation of Francisco J. Coll.
On November 15, 2024, Gregory M. Share informed the Board of Directors (the “Board”) of Runway Growth Finance Corp., a Maryland corporation (the “Company”), of his intent to resign as a director of the Company.
Appointment of Director Effective November 18, 2024, the Board appointed Michael J. Hildebrandt to serve as an independent director
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
In addition, Mr. Chee resigned from the Board of Directors and all committees or subcommittees thereof, effective upon his termination of employment on November 22, 2024.
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
On November 12, 2024, Andrew M. Oh notified the Board of Directors of the Company of his resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Stacy J. Smith has been appointed as Lead Independent Director.
elected and appointed Bruce Haase as a member of the Board and as a member of the Human Capital Management Committee of the Board.
John K. Tien, Jr. was appointed as a member of the Board of Directors of the Company (the “Board”) for an initial term beginning on December 2, 2024 (the “Effective Date”) and expiring at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
Jay Giraud, Karan Sodhi, Shashi Tripathi, Bal Bhullar and Melanie Figueroa were appointed as members of the board of directors
Jay Giraud, Karan Sodhi, Shashi Tripathi, Bal Bhullar and Melanie Figueroa were appointed as members of the board of directors
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.